Esketamine for irritable bowel syndrome with anxiety or depression
Treatments studied
Part of Digestive system clinical trials.
This study tests if esketamine, a fast-acting medication, can help people with irritable bowel syndrome who also have anxiety or depression. It is given during a colonoscopy to see if it reduces your IBS symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have been diagnosed with irritable bowel syndrome (IBS) based on Rome IV criteria.
- You also have a diagnosis of anxiety disorder or major depression.
- You are scheduled for a colonoscopy.
- Your body mass index (BMI) is between 15 and 30.
- You are in generally good physical health (ASA I or II).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called esketamine (given during anesthesia) can help reduce anxiety, sadness, or other negative emotions that often occur before and after breast cancer surgery. This could help you feel better emotionally during your recovery.
This trial tests how treatment with esketamine affects metabolism in people with depression. It may help if you have not responded to at least two standard antidepressants.
This trial studies whether esketamine given around the time of breast cancer surgery can improve depression and change gut bacteria. It also monitors your sleep/deep anesthesia level (with a simple monitoring number).
This trial tests whether esketamine, an anesthetic, can help reduce severe depression symptoms in women having breast cancer surgery. You may qualify if you have severe depression before surgery.
This trial tests whether giving a medication called esketamine during breast cancer surgery can help reduce negative emotions like depression and anxiety after surgery. It is for women who already have mild to severe depression symptoms.
This trial tests a combination of two sedative medicines (Remimazolam and Esketamine) for elderly patients having a painless stomach and colon exam. The goal is to see if this combination is safe and effective for older adults.
Hear when a new Irritable Bowel Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.